Advertisement

Topics

Patent granted for method of use of Acucela’s Stargardt disease treatment

08:18 EDT 14 Sep 2017 | Healio

The U.S. Patent and Trademark Office granted U.S. Patent No. 9,737,496 B2 to Acucela for method of use of its Stargardt disease treatment emixustat hydrochloride or a “broad number of related compounds,” according to a company press release.Emixustat was granted orphan drug designation in January for the treatment of Stargardt disease, which affects fewer than 40,000 patients in the United States.

Original Article: Patent granted for method of use of Acucela’s Stargardt disease treatment

NEXT ARTICLE

More From BioPortfolio on "Patent granted for method of use of Acucela’s Stargardt disease treatment"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...